The single meningococcal vaccine is pentavalent — meaning it protects against five different meningococcal groups: A, B, C, W and Y.
The advisory committee voted 10-4 in favor of recommending the vaccine for use when current options of an MenACWY vaccine and MenB are recommended in the same visit, which is the case “for healthy individuals ages 16–23 years who choose to receive MenB vaccination and individuals 10 years and older who are at increased risk,” according to information published by the American Academy of Pediatrics.
Now that the advisory committee has given its recommendations, CDC Director Mandy Cohen, MD, will review them and decide on their approval.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
